Cross Laps assay estimates carboxy-terminal collagen crosslinks (CTX) in serum. This measurement is reported to be more specific to bone resorption than other measurements. This assay is sensitive and depicts greater utility for healthcare professionals in assessing efficacy of antiresorptive treatment in postmenopausal women undergoing treatment of Osteoporosis and people diagnosed with Osteopenia.